Janus Henderson Group PLC grew its holdings in shares of Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 27.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,497,368 shares of the company's stock after purchasing an additional 1,184,450 shares during the quarter. Janus Henderson Group PLC owned about 4.32% of Surgery Partners worth $177,235,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors have also recently bought and sold shares of SGRY. Quarry LP boosted its position in Surgery Partners by 133.1% in the second quarter. Quarry LP now owns 3,082 shares of the company's stock valued at $73,000 after buying an additional 1,760 shares in the last quarter. KBC Group NV increased its stake in Surgery Partners by 31.8% in the third quarter. KBC Group NV now owns 2,385 shares of the company's stock valued at $77,000 after purchasing an additional 576 shares in the last quarter. DekaBank Deutsche Girozentrale increased its stake in Surgery Partners by 102.0% in the first quarter. DekaBank Deutsche Girozentrale now owns 2,723 shares of the company's stock valued at $80,000 after purchasing an additional 1,375 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. increased its stake in Surgery Partners by 747.6% in the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 3,831 shares of the company's stock valued at $124,000 after purchasing an additional 3,379 shares in the last quarter. Finally, Creative Planning bought a new stake in Surgery Partners in the third quarter valued at approximately $258,000.
Analyst Upgrades and Downgrades
SGRY has been the subject of several research analyst reports. Cantor Fitzgerald reiterated an "overweight" rating and issued a $43.00 price target on shares of Surgery Partners in a report on Friday, October 4th. Benchmark reiterated a "buy" rating and issued a $50.00 price target on shares of Surgery Partners in a research note on Monday, August 26th. Macquarie reissued an "outperform" rating and issued a $34.00 price objective on shares of Surgery Partners in a research report on Tuesday, November 19th. StockNews.com lowered shares of Surgery Partners from a "hold" rating to a "sell" rating in a research report on Wednesday, August 7th. Finally, KeyCorp started coverage on shares of Surgery Partners in a research report on Friday, October 11th. They set a "sector weight" rating on the stock. One analyst has rated the stock with a sell rating, three have assigned a hold rating and six have issued a buy rating to the company's stock. According to MarketBeat, Surgery Partners presently has a consensus rating of "Moderate Buy" and an average price target of $37.38.
Read Our Latest Research Report on Surgery Partners
Surgery Partners Stock Down 2.1 %
SGRY stock traded down $0.48 during midday trading on Wednesday, reaching $22.52. 1,607,111 shares of the company's stock traded hands, compared to its average volume of 975,822. The company has a market cap of $2.86 billion, a price-to-earnings ratio of -46.92, a P/E/G ratio of 19.82 and a beta of 2.58. The firm's fifty day moving average price is $28.42 and its 200-day moving average price is $28.17. The company has a quick ratio of 1.66, a current ratio of 1.80 and a debt-to-equity ratio of 0.99. Surgery Partners, Inc. has a 52 week low of $21.36 and a 52 week high of $36.92.
Surgery Partners (NASDAQ:SGRY - Get Free Report) last posted its quarterly earnings data on Tuesday, November 12th. The company reported $0.19 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.25 by ($0.06). The firm had revenue of $770.40 million for the quarter, compared to analysts' expectations of $768.99 million. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. Surgery Partners's revenue was up 14.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.15 earnings per share. As a group, sell-side analysts forecast that Surgery Partners, Inc. will post 0.73 earnings per share for the current fiscal year.
About Surgery Partners
(
Free Report)
Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.
Featured Articles
Before you consider Surgery Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Surgery Partners wasn't on the list.
While Surgery Partners currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.